Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Nat Immunol. 2023 Oct 23;24(12):2150–2163. doi: 10.1038/s41590-023-01654-3

Table 1. Human samples used in this study.

General information and specific assays samples were used for. UD, undetectable; NA, non-applicable; ND, not determined; UA, unavailable; equiv, equivocal; FC, flow cytometry; 1°, primary; 2°, secondary.

General information
Assays samples were used for
ID Diagnosis Age Gender Dengue exposure Viral load (copies/ml) Day of fever Days before SD viscRNA-Seq 2 Cytokines Co-culture Uptake FC target cells FC functional

1–140 SD 16 F UD 5 <1 v v
5–030 SD 4 F 5.84 E5 6 2 v v
5–041 SD 13 F 4.91 E4 5 1 v v
5–044 SD 11 F 5.11 E7 5 1 v v
5–193 SD 5 M UD 5 2 v v
1–144 SD 17 M 9.12 E3 7 1 v v
1–002 SD 16 F 5.57 E4 4 <1 v v

6–023 D 11 M UD 6 - v v
6–029 D 11 F 1.78 E2 7 - v v
1–019 D 13 F UD 2 - v v
5–154 D 5 F ND 2.69 E8 4 - v v
5–130 D 12 M UD 7 - v v
5–010 D 10 F 3.61 E6 7 - v v
6–001 D 15 M 9.02 E8 3 - v v
1–113 D 17 M 8.13 E3 1 - v v

5–089 DWS 11 M 2.46 E9 3 - v
6–020 DWS 13 F 2.00 E10 2 - v
6–025 DWS 6 M equiv 1.23 E10 3 - v
6–028 DWS 5 M 8.07 E9 6 - v

3–073 H 13 F NA NA NA - v
3–074 H 8 F NA NA NA - v
3–012 H 12 M NA NA NA - v
3–047 H 5 M NA NA NA - v

6–031 DWS 23 F 5.17 E5 5 - v v v
6–007 DWS 14 M 1.62 E9 2 - v v v
5–055 DWS 12 M 1.99 E6 5 - v v v
5–011 DWS 17 F 4.66 E8 4 - v v v
1–151 DWS 29 M 4.64 E9 2 - v v v
5–216 DWS 32 M 2.54 E5 3 - v v
1–087 DWS 9 F UD 4 - v v
1–095 DWS 6 M UD 7 - v v
1–116 DWS 10 F UD 5 - v v
1–118 DWS 20 M 4.79 E2 2 - v v
1–129 DWS 53 F 2.56 E4 7 - v v

#1 H (bank) 36 M NA NA NA - v v
#2 H (bank) 27 M NA NA NA - v v
#3 H (bank) 33 F NA NA NA - v v
#4 H (bank) 41 M NA NA NA - v v
#5 H (bank) 29 F NA NA NA - v v